Bienengräber V
Arch Geschwulstforsch. 1986;56(5):353-6.
Reported on therapeutic study by 20 patients with inoperable carcinoma of the oral cavity. Primary we made a systemic antineoplastic chemotherapy with combination of methotrexate, bleomycine and vincristine. After the cytostatic therapy we lead through an operative revision or a radiological treatment. The patients live on an average 11.5 months. This is not longer than in the control-group with solitary radiological treatment. At present we cannot recommend the neoadjuvant chemotherapy of progressive squamous cell carcinomas of the oral cavity.
报告了20例口腔无法手术切除的癌患者的治疗研究。首先,我们采用甲氨蝶呤、博来霉素和长春新碱联合进行全身抗肿瘤化疗。在细胞抑制治疗后,我们进行手术修正或放射治疗。患者平均存活11.5个月。这并不比单纯接受放射治疗的对照组更长。目前,我们不推荐对进展期口腔鳞状细胞癌进行新辅助化疗。